Trejo-Acuña JJRJ, Navarrete-Franco G, Ramírez-Valverde AG, Jiménez-Herrera EA

Language: Spanish
References: 10
Page: 16-19
PDF size: 233.76 Kb.

ABSTRACT

Leishmaniasis is a group of infectious diseases caused by the protozoan Leishmania spp. The main clinical forms are visceral (also called kala-azar), muco-cutaneous and cutaneous. In Mexico, it is considered a neglected disease that affects marginal and low-income populations. In this article we present the case of a 16-year-old male patient with localized cutaneous Leishmaniasis.

REFERENCES

1. García-Almagro, D. Leishmaniasis cutánea. Actas Dermosifiliogr. 2005; 96: 1-24. doi: 10.1016/S0001-7310(05)73027-1.

2. Pereira A, Pérez M. Leishmaniosis. Parasitología. 2002; 21: 117-124.

3. Manual para el diagnóstico, tratamiento y control de las Leishmaniasis. Centro Nacional de Vigilancia Epidemiológica y Control de Enfermedades. 2015. Recuperado en: http://www.cenaprece.salud.gob.mx/programas/interior/vectores/descargas/pdf/ManualLeishmaniasis2015.pdf.

4. The Center for food security and public health. Leishmaniasis (cutánea y visceral). 2009; Recovered in: http://www.cfsph.iastate.edu/DiseaseInfo/disease.php?name=leishmaniasis&lang=es.

5. Scott P. Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol. 2016; 16: 581-592.

6. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000 Res. 2017; 6: 750.

7. Alemayehu, B, Alemayehu M. Leishmaniasis: a review on parasite, vector and reservoir host. Health Sci J. 2017; 11: 1-6.

8. Rosal-Rabes T, Baquero-Artigao F, Miguel G. Leishmaniasis cutánea. Rev Pediatr Atern Primaria. 2010; 12: 263-271.

9. Monzote L. Current treatment of leishmaniasis: a review. The Open Antimicrobial Agents Journal. 2009; 1: 9-19.

10. Savoia D. Recent updates and perspectives on leishmaniasis. J Infect Dev Ctries. 2015; 9: 588-596.